Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA

Fig. 5

Impacts of contextual criteria on the appraisal of lenvatinib assigned by panelists in France, Italy and Spain, as percentage of impacts assigned. *Percentage of impacts (positive or negative) of all impacts assigned for a given criterion; Overall impact across criteria = (∑ Positive impacts - ∑ Negative impacts) / ∑ all impacts assigned

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us